Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Prepaid Assets: 2022-2025

Historic Prepaid Assets for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $7.7 million.

  • Stoke Therapeutics' Prepaid Assets fell 21.25% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year decrease of 21.25%. This contributed to the annual value of $11.1 million for FY2024, which is 1.79% down from last year.
  • According to the latest figures from Q3 2025, Stoke Therapeutics' Prepaid Assets is $7.7 million, which was down 43.43% from $13.7 million recorded in Q2 2025.
  • In the past 5 years, Stoke Therapeutics' Prepaid Assets ranged from a high of $13.7 million in Q2 2025 and a low of $7.7 million during Q3 2025.
  • Its 3-year average for Prepaid Assets is $10.9 million, with a median of $10.9 million in 2023.
  • Over the last 5 years, Stoke Therapeutics' Prepaid Assets had its largest YoY gain of 32.37% in 2025, and its largest YoY loss of 21.25% in 2025.
  • Quarterly analysis of 4 years shows Stoke Therapeutics' Prepaid Assets stood at $10.9 million in 2022, then increased by 3.55% to $11.3 million in 2023, then declined by 1.79% to $11.1 million in 2024, then decreased by 21.25% to $7.7 million in 2025.
  • Its Prepaid Assets was $7.7 million in Q3 2025, compared to $13.7 million in Q2 2025 and $12.7 million in Q1 2025.